The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies
Mohammad Reza Sadeghi(Tabriz University of Medical Sciences), Farhad Jadidi-Niaragh(Tabriz University of Medical Sciences), Hamed Mohammadi(Tehran University of Medical Sciences), Armin Ahmadi(University of Alabama in Huntsville), Atefeh Khodakarami(Tabriz University of Medical Sciences), Ali Akbari(Harvard University), Mehdi Yousefi(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Mehrdad Fathi(Kurdistan University of Medical Sciences), Jamshid Gholizadeh Navashenaq(Bam University of Medical Sciences)
Cited by 16
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202